Evaluation of The Effect of 980nm Diode Laser Intracanal Irradiation on Levels of Interleukin-8 Expression

August 17, 2023 updated by: Dina Ahmed Morsy, Cairo University

Evaluation of The Effect of 980nm Diode Laser Intracanal Irradiation on Levels of Interleukin-8 Expression in Lesions Refractory to Endodontic Treatment: A Randomized Control Trial

This clinical trial will be conducted to evaluate the amount of Il-8 expression before and after the application of intracanal irradiation with diode laser 980 nm versus placebo in failed endodontic cases with periapical lesions.

Study Overview

Detailed Description

  • Thorough medical and dental history for the eligible patients
  • Thorough intraoral and extraoral diagnosis
  • Local anesthesia
  • Isolation and removal of any previous filling or restoration
  • Removal of old gutta percha and establish patency to the full working length.
  • 1st sample: will be collected using 3 sterile paper points
  • Chemo-mechanical preparation.
  • 2nd sample collection

    • Laser group: The canals will be irradiated with a high-power diode laser, with wavelength of 980 nm, maximum output of 3 watts and coupled with a fiber optic tip of 200 µm diameter.

    • Mock laser application (Placebo group): The fiberoptic tip will be inserted inside the root canal, mimicking the laser irradiation, but not activated.

  • 3rd sample collection
  • A piece of dry cotton will be placed in the access cavity, and then will be sealed with glass ionomer filling material
  • 2nd visit: 1 week later, 4th sample collection then Obturation
  • Number of visits & follow up period: Two visits

Study Type

Interventional

Enrollment (Actual)

28

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt, 11553
        • Faculty of Dentistry

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 33 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • failed previously treated endodontic single-rooted teeth with chronic periapical lesions; with radiographic evidence of periapical radiolucency of not less than 1 cm diameter will be selected.
  • Teeth with straight root canals.
  • No contributory medical history.
  • No previous administration of analgesics and/or antibiotics within the previous 2 weeks.

Exclusion Criteria:

  • Retreatment cases with complications such as separated instruments, perforations, ledges, resorption, transportation, calcifications, immature apices and over fillings.
  • Teeth with curved roots.
  • Swelling or sinus tract.
  • Mutilated teeth that interfere with proper isolation and seal between visits.
  • Subjects with generalized periodontitis, or if the tooth has a probing depth of more than 3 mm.
  • Subjects with uncontrolled diabetes or debilitating diseases.
  • Pregnant or nursing females.
  • Systemic disorders that necessitate antibiotic prophylaxis or prevent the use of Ibuprofen.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Placebo group
• Mock laser application (Placebo group): The fiber optic tip will be inserted inside the root canal, mimicking the laser irradiation group, but not activated

After endodontic retreatment, mock laser application (Placebo group) will be applied:

The fiberoptic tip will be inserted inside the root canal, mimicking the laser irradiation group, but not activated

Other: Diode Laser group
Intracanal Diode laser application
After endodontic retreatment, root canals will be irradiated with a 980 nm diode laser coupled with optical fibre 200 μm (Litemedics, Italy) with setting 1.2-watt power, in pulsed mode. The irradiation protocol will be of 5-sec irradiation followed by a 10-sec pause, which constituted one lasing cycle. The lasing cycle will be performed four times for each tooth. The tip will be positioned 1 mm short of the apex. Followed by activation during which it will be slowly dragged at a speed of approximately 2 mm/ sec in a way that the root canals will be irradiated from the apical to the coronal portion, in a helicoidal movement touching the canal walls.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
quantification of IL-8
Time Frame: one week
- After collection of all the samples, quantification of IL-8 will be determined using ELISA kit before (S-1), after chemo-mechanical preparation (S-2), after intracanal irradiation or placebo effect (S-3) and last after one week of the treatment (S-4). The kit is used according to the manufacturer's recommendations.
one week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative pain
Time Frame: 6, 12, 24 hours and 7 days
Following the first visit, the modified visual analogue scale (VAS scale) with 11 points where 0 means no pain and 10 means maximum pain will be used to record patient's level of pain
6, 12, 24 hours and 7 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Dina A Morsy, lecturer, Cairo University
  • Principal Investigator: Sherif A Elkhodary, assoc. Prof, Cairo University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 14, 2021

Primary Completion (Actual)

March 22, 2022

Study Completion (Actual)

April 27, 2022

Study Registration Dates

First Submitted

October 28, 2022

First Submitted That Met QC Criteria

October 28, 2022

First Posted (Actual)

November 3, 2022

Study Record Updates

Last Update Posted (Actual)

August 21, 2023

Last Update Submitted That Met QC Criteria

August 17, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Endodontically Treated Teeth

Clinical Trials on Placebo

3
Subscribe